Awake burr hole craniotomy for chronic subdural hematoma: a phase 2 randomized controlled trial

Robert Mertens(Humboldt-Universität zu Berlin), Lars Wessels(Humboldt-Universität zu Berlin), Claudius Jelgersma(Humboldt-Universität zu Berlin), Peter Truckenmüller(Humboldt-Universität zu Berlin), Clara F. Weber(Montreal Neurological Institute and Hospital), Claudia Spies(Apple (Israel)), Sascha Treskatsch(Humboldt-Universität zu Berlin), Ahmad Almahozi(Charité - Universitätsmedizin Berlin), Philipp Spindler(Humboldt-Universität zu Berlin), Lukas Depperich(Charité - Universitätsmedizin Berlin), Nils Hecht(Charité - Universitätsmedizin Berlin), Anton Früh(Humboldt-Universität zu Berlin), Kiarash Ferdowssian(Humboldt-Universität zu Berlin), Theresa Keller(Humboldt-Universität zu Berlin), Erin Sprünken(Humboldt-Universität zu Berlin), Alawi Lütz(Charité - Universitätsmedizin Berlin), Anika Müller(Humboldt-Universität zu Berlin), Friederike Töpper(Charité - Universitätsmedizin Berlin), Peter Vajkoczy(Humboldt-Universität zu Berlin)
Critical Care
March 9, 2026
10.1186/s13054-026-05913-1
Cited by 0

Related Papers

Mortality after surgery in Europe: a 7 day cohort study
|The Lancet|2012|1.4k
A positive fluid balance is associated with a worse outcome in patients with acute renal failure
|Critical Care|2008|954
Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems
|Intensive Care Medicine|2012|637
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
|The Lancet|2019|581
Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage
|Brain|2009|549